<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9">
 <label>9.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cohen</surname>
    <given-names>RD</given-names>
   </name>
   <name>
    <surname>Bhayat</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Blake</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Travis</surname>
    <given-names>S</given-names>
   </name>
  </person-group>. 
  <article-title>The safety profile of vedolizumab in ulcerative colitis and Crohn's disease: 4 years of global post-marketing data</article-title>. 
  <source>J Crohns Colitis.</source> (
  <year>2019</year>) 
  <volume>14</volume>:
  <fpage>192</fpage>â€“
  <lpage>204</lpage>. 
  <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjz137</pub-id>
  <?supplied-pmid 31504340?>
  <pub-id pub-id-type="pmid">31504340</pub-id>
 </mixed-citation>
</ref>
